Primary diffuse large B-cell lymphoma of the stomach

Andrés J M Ferreri, Carlos Montalbán

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

The stomach is the extranodal site most commonly involved by non-Hodgkin lymphomas. Diffuse large B-cell lymphoma is the most common histotype category arising in this organ. This is an aggressive lymphoma usually presenting as limited disease, being associated or not to Helicobacter pylori infection and mucosa-associated lymphoid tissue-type areas. Histopathological characteristics are similar to those reported for other diffuse large B-cell lymphomas. It occurs more frequently in males with a median age ranging between 50 and 60 years. With an adequate therapeutic strategy, its prognosis is good, with a 5-year overall survival near to 90%. Conservative treatment with anthracycline-containing chemotherapy, followed or not by involved-field radiotherapy has replaced gastrectomy as standard approach against this malignancy. Several questions on the best treatment remain unanswered. Among others, the role of rituximab, consolidation radiotherapy as well as of more conservative approaches like H. pylori-eradicating antibiotic therapy should be better defined.

Original languageEnglish
Pages (from-to)65-71
Number of pages7
JournalCritical Reviews in Oncology/Hematology
Volume63
Issue number1
DOIs
Publication statusPublished - Jul 2007

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Stomach
Helicobacter pylori
Radiotherapy
Anthracyclines
Helicobacter Infections
Lymphoid Tissue
Gastrectomy
Non-Hodgkin's Lymphoma
Lymphoma
Mucous Membrane
Therapeutics
Anti-Bacterial Agents
Drug Therapy
Neoplasms

Keywords

  • B-cell lymphoma
  • Chemotherapy
  • Diffuse large B-cell lymphoma
  • Helicobacter pylori
  • Radiotherapy
  • Rituximab
  • Staging

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Primary diffuse large B-cell lymphoma of the stomach. / Ferreri, Andrés J M; Montalbán, Carlos.

In: Critical Reviews in Oncology/Hematology, Vol. 63, No. 1, 07.2007, p. 65-71.

Research output: Contribution to journalArticle

@article{c7fbde40571649ce9b0720aefc0554c2,
title = "Primary diffuse large B-cell lymphoma of the stomach",
abstract = "The stomach is the extranodal site most commonly involved by non-Hodgkin lymphomas. Diffuse large B-cell lymphoma is the most common histotype category arising in this organ. This is an aggressive lymphoma usually presenting as limited disease, being associated or not to Helicobacter pylori infection and mucosa-associated lymphoid tissue-type areas. Histopathological characteristics are similar to those reported for other diffuse large B-cell lymphomas. It occurs more frequently in males with a median age ranging between 50 and 60 years. With an adequate therapeutic strategy, its prognosis is good, with a 5-year overall survival near to 90{\%}. Conservative treatment with anthracycline-containing chemotherapy, followed or not by involved-field radiotherapy has replaced gastrectomy as standard approach against this malignancy. Several questions on the best treatment remain unanswered. Among others, the role of rituximab, consolidation radiotherapy as well as of more conservative approaches like H. pylori-eradicating antibiotic therapy should be better defined.",
keywords = "B-cell lymphoma, Chemotherapy, Diffuse large B-cell lymphoma, Helicobacter pylori, Radiotherapy, Rituximab, Staging",
author = "Ferreri, {Andr{\'e}s J M} and Carlos Montalb{\'a}n",
year = "2007",
month = "7",
doi = "10.1016/j.critrevonc.2007.01.003",
language = "English",
volume = "63",
pages = "65--71",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Primary diffuse large B-cell lymphoma of the stomach

AU - Ferreri, Andrés J M

AU - Montalbán, Carlos

PY - 2007/7

Y1 - 2007/7

N2 - The stomach is the extranodal site most commonly involved by non-Hodgkin lymphomas. Diffuse large B-cell lymphoma is the most common histotype category arising in this organ. This is an aggressive lymphoma usually presenting as limited disease, being associated or not to Helicobacter pylori infection and mucosa-associated lymphoid tissue-type areas. Histopathological characteristics are similar to those reported for other diffuse large B-cell lymphomas. It occurs more frequently in males with a median age ranging between 50 and 60 years. With an adequate therapeutic strategy, its prognosis is good, with a 5-year overall survival near to 90%. Conservative treatment with anthracycline-containing chemotherapy, followed or not by involved-field radiotherapy has replaced gastrectomy as standard approach against this malignancy. Several questions on the best treatment remain unanswered. Among others, the role of rituximab, consolidation radiotherapy as well as of more conservative approaches like H. pylori-eradicating antibiotic therapy should be better defined.

AB - The stomach is the extranodal site most commonly involved by non-Hodgkin lymphomas. Diffuse large B-cell lymphoma is the most common histotype category arising in this organ. This is an aggressive lymphoma usually presenting as limited disease, being associated or not to Helicobacter pylori infection and mucosa-associated lymphoid tissue-type areas. Histopathological characteristics are similar to those reported for other diffuse large B-cell lymphomas. It occurs more frequently in males with a median age ranging between 50 and 60 years. With an adequate therapeutic strategy, its prognosis is good, with a 5-year overall survival near to 90%. Conservative treatment with anthracycline-containing chemotherapy, followed or not by involved-field radiotherapy has replaced gastrectomy as standard approach against this malignancy. Several questions on the best treatment remain unanswered. Among others, the role of rituximab, consolidation radiotherapy as well as of more conservative approaches like H. pylori-eradicating antibiotic therapy should be better defined.

KW - B-cell lymphoma

KW - Chemotherapy

KW - Diffuse large B-cell lymphoma

KW - Helicobacter pylori

KW - Radiotherapy

KW - Rituximab

KW - Staging

UR - http://www.scopus.com/inward/record.url?scp=34249324868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249324868&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2007.01.003

DO - 10.1016/j.critrevonc.2007.01.003

M3 - Article

VL - 63

SP - 65

EP - 71

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 1

ER -